These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 19787796

  • 1. HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants.
    Barton JC, Lafreniere SA, Leiendecker-Foster C, Li H, Acton RT, Press RD, Eckfeldt JH.
    Am J Hematol; 2009 Nov; 84(11):710-4. PubMed ID: 19787796
    [Abstract] [Full Text] [Related]

  • 2. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC, Acton RT, Leiendecker-Foster C, Lovato L, Adams PC, McLaren GD, Eckfeldt JH, McLaren CE, Reboussin DM, Gordeuk VR, Speechley MR, Reiss JA, Press RD, Dawkins FW, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators.
    Genet Test; 2007 Nov; 11(3):269-75. PubMed ID: 17949288
    [Abstract] [Full Text] [Related]

  • 3. Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 hemochromatosis and iron overload screening (HEIRS) study participants.
    Acton RT, Barton JC, Leiendecker-Foster C, Zaun C, McLaren CE, Eckfeldt JH.
    Blood Cells Mol Dis; 2010 Apr 15; 44(4):252-6. PubMed ID: 20178892
    [Abstract] [Full Text] [Related]

  • 4. Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients.
    Santos PC, Cançado RD, Pereira AC, Schettert IT, Soares RA, Pagliusi RA, Hirata RD, Hirata MH, Teixeira AC, Figueiredo MS, Chiattone CS, Krieger JE, Guerra-Shinohara EM.
    Blood Cells Mol Dis; 2011 Apr 15; 46(4):302-7. PubMed ID: 21411349
    [Abstract] [Full Text] [Related]

  • 5. Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screening.
    Barton JC, Acton RT, Leiendecker-Foster C, Lovato L, Adams PC, Eckfeldt JH, McLaren CE, Reiss JA, McLaren GD, Reboussin DM, Gordeuk VR, Speechley MR, Press RD, Dawkins FW, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators.
    Am J Hematol; 2008 Feb 15; 83(2):126-32. PubMed ID: 17726683
    [Abstract] [Full Text] [Related]

  • 6. Hereditary hemochromatosis type 1 phenotype modifiers in Italian patients. The controversial role of variants in HAMP, BMP2, FTL and SLC40A1 genes.
    Radio FC, Majore S, Aurizi C, Sorge F, Biolcati G, Bernabini S, Giotti I, Torricelli F, Giannarelli D, De Bernardo C, Grammatico P.
    Blood Cells Mol Dis; 2015 Jun 15; 55(1):71-5. PubMed ID: 25976471
    [Abstract] [Full Text] [Related]

  • 7. Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload.
    Biasiotto G, Belloli S, Ruggeri G, Zanella I, Gerardi G, Corrado M, Gobbi E, Albertini A, Arosio P.
    Clin Chem; 2003 Dec 15; 49(12):1981-8. PubMed ID: 14633868
    [Abstract] [Full Text] [Related]

  • 8. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation.
    Velati C, Marlianici E, Rigamonti D, Barillari G, Chiavilli F, Fugiani P, Garozzo G, Lancieri M, Rinaldi S, Testa D, Sampietro M, Tavazzi D, Delbini P, Fargion S, Fiorelli G.
    Hematol J; 2003 Dec 15; 4(6):436-40. PubMed ID: 14671617
    [Abstract] [Full Text] [Related]

  • 9. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
    De Gobbi M, D'Antico S, Castagno F, Testa D, Merlini R, Bondi A, Camaschella C.
    Haematologica; 2004 Oct 15; 89(10):1161-7. PubMed ID: 15477198
    [Abstract] [Full Text] [Related]

  • 10. Analysis of HFE and TFR2 mutations in selected blood donors with biochemical parameters of iron overload.
    De Gobbi M, Daraio F, Oberkanins C, Moritz A, Kury F, Fiorelli G, Camaschella C.
    Haematologica; 2003 Apr 15; 88(4):396-401. PubMed ID: 12681966
    [Abstract] [Full Text] [Related]

  • 11. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis.
    Merryweather-Clarke AT, Cadet E, Bomford A, Capron D, Viprakasit V, Miller A, McHugh PJ, Chapman RW, Pointon JJ, Wimhurst VL, Livesey KJ, Tanphaichitr V, Rochette J, Robson KJ.
    Hum Mol Genet; 2003 Sep 01; 12(17):2241-7. PubMed ID: 12915468
    [Abstract] [Full Text] [Related]

  • 12. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators.
    N Engl J Med; 2005 Apr 28; 352(17):1769-78. PubMed ID: 15858186
    [Abstract] [Full Text] [Related]

  • 13. HFE genotype and parameters of iron metabolism in German first-time blood donors - evidence for an increased transferrin saturation in C282Y heterozygotes.
    Raddatz D, Legler T, Lynen R, Addicks N, Ramadori G.
    Z Gastroenterol; 2003 Nov 28; 41(11):1069-76. PubMed ID: 14648375
    [Abstract] [Full Text] [Related]

  • 14. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study.
    Barton JC, Acton RT, Dawkins FW, Adams PC, Lovato L, Leiendecker-Foster C, McLaren CE, Reboussin DM, Speechley MR, Gordeuk VR, McLaren GD, Sholinsky P, Harris EL.
    Genet Test; 2005 Nov 28; 9(3):231-41. PubMed ID: 16225403
    [Abstract] [Full Text] [Related]

  • 15. The hepcidin gene promoter nc.-1010C > T; -582A > G haplotype modulates serum ferritin in individuals carrying the common H63D mutation in HFE gene.
    Silva B, Pita L, Gomes S, Gonçalves J, Faustino P.
    Ann Hematol; 2014 Dec 28; 93(12):2063-6. PubMed ID: 25015054
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients.
    Phatak PD, Ryan DH, Cappuccio J, Oakes D, Braggins C, Provenzano K, Eberly S, Sham RL.
    Blood Cells Mol Dis; 2002 Dec 28; 29(1):41-7. PubMed ID: 12482402
    [Abstract] [Full Text] [Related]

  • 17. Mutations in HAMP and HJV genes and their impact on expression of clinical hemochromatosis in a cohort of 100 Spanish patients homozygous for the C282Y mutation of HFE gene.
    Altès A, Bach V, Ruiz A, Esteve A, Felez J, Remacha AF, Sardà MP, Baiget M.
    Ann Hematol; 2009 Oct 28; 88(10):951-5. PubMed ID: 19214511
    [Abstract] [Full Text] [Related]

  • 18. [Study on HFE gene mutations in patients with myelodysplastic syndromes and aplastic anemia].
    Nie L, Ai XF, Zheng YZ, Li QH, Yang L, Xiao ZJ.
    Zhonghua Xue Ye Xue Za Zhi; 2009 Apr 28; 30(4):223-8. PubMed ID: 19731820
    [Abstract] [Full Text] [Related]

  • 19. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
    Adams PC, Reboussin DM, Barton JC, Acton RT, Speechley M, Leiendecker-Foster C, Meenan R, Passmore L, McLaren CE, McLaren GD, Gordeuk V, Dawkins F, Eckfeldt JH.
    Int J Lab Hematol; 2008 Aug 28; 30(4):300-5. PubMed ID: 18665827
    [Abstract] [Full Text] [Related]

  • 20. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
    Valenti L, Pulixi EA, Arosio P, Cremonesi L, Biasiotto G, Dongiovanni P, Maggioni M, Fargion S, Fracanzani AL.
    Haematologica; 2007 Aug 28; 92(8):1037-42. PubMed ID: 17640859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.